BVA-100
Commercial- Indications
- Heart failure, Critical care, Blood volume disorders
Company intelligence / Profile preview
Daxor
Oak Ridge, Tennessee, USAzoominfo.com ↗
- Ownership
- Public · DXR
- Employees
- ~25
- Development stage
- Commercial
01
Overview
Daxor’s BVA‑100™ Blood Volume Analyzer has been FDA-cleared and used in over 65,000 tests. Clinical studies have demonstrated improved patient outcomes through accurate blood volume measurement for fluid management across heart failure, critical care, sepsis/ARDS, syncope, and surgical settings. Ongoing development includes a rapid point-of-care version for both military and civilian use.
- Therapeutic areas
- OtherHematologyCritical CareCardiovascular
- Modalities
- DeviceDiagnostic test (Blood Volume Analyzer)
- Industry
- Physiological Monitoring
02
Drug pipeline
1 asset03
Partnerships
U.S. Army/DOD SBIR program for POC device developmentValue Initiative Industry Alliance Partner with SNMMIclinical collaborations with major academic centers including Columbia University, Duke Health, Geisinger, Mayo Clinic, NYU Langone Health/Yale/Vanderbilt/Virginia Commonwealth University
04
Financials
- Market cap
- $61.1M
- Total revenue
- $23K
- Enterprise value
- $55.3M
Beyond the preview
Go deeper on Daxor.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Daxor.